In this webinar we will present both clinical and technical aspects of our hypofractationed approach to whole breast, partial breast and breast reirradation using TomoTherapy®. We will describe how we select patient for TomoDirect™ and TomoHelical™ modalities, and will share details of our Phase I/II clinical trial on single fraction ablative preoperative radiation treatment for early-stage breast cancer.
Samantha Dicuonzo, M.D. – European Institute of Oncology (IEO) Milan, Italy
Samantha Dicuonzo graduated with a degree in Medicine from the University of Milan in 2011 and completed her specialization in Radiation Oncology in 2017, also at the University of Milan, Italy. Dr. Dicuonzo has worked as a fellow at the Division of Radiation Therapy at the European Institute of Oncology, IEO, IRCCS, Milan, Italy and in 2017 she was appointed Staff Radiation Oncologist. Her specialties include 3D conformal radiotherapy, intensity modulated radiotherapy (IMRT), hypofractionation, image-guided radiotherapy (IGRT). Her main clinical and scientific interests are breast cancer, cutaneous cancer and malignant sarcomas. She is a member of the Italian Association of Radiation Oncology and Clinical Oncology (AIRO) and in 2017 she was awarded a grant by “Fondazione IEO-CCM” for the HALFMOON-study (Helical ALtered Fractionation for iMplant partial OmissiON). Dr. Dicuonzo’s pivotal publications focus on breast, prostate cancer, gynecological tumors, brachytherapy and malignant sarcomas.
Raffaella Cambria, M.Sc. – European Institute of Oncology (IEO) Milan, Italy
Raffaella Cambria received her masters degree in Nuclear Physics in 1990 at the Università degli Studi di Milano and in the 9 years that followed was a researcher in the Italian Hadrontherapy Project, where her research centered around new dosimeters for clinical proton beams. In 1999 Mrs Cambria was hired as a senior assistant at the European Institute of Oncology (IEO) of Milan (Italy), directed by Dr R. Orecchia. She was appointed Deputy Director in the Medical Physics department in 2015. She is an expert in the latest radiotherapy techniques and planning, including IMRT, VMAT, stereotactic cranial and extracranial treatments, and image guided radiotherapy. Mrs Cambria has authored more than forty articles on peer-reviewed journals and is Associate Professor at the Università degli Studi di Milano, both for the postgraduate radiotherapy school of medicine and radiotherapy technicians.
Moderated by: Maria-Amelia Rodrigues, M.D. – Miami Cancer Institute, Miami, FL, USA
Maria-Amelia Rodrigues, M.D., is a radiation oncologist at Miami Cancer Institute, a part of Baptist Health South Florida. She received her medical degree from the University of Rio de Janeiro School of Medicine in Brazil and completed an internship in internal medicine at Hospital de Clinicas Gaffree Guinle, University of Rio de Janeiro, and the Kaiser Foundation Medical Center, San Francisco. She also completed a residency in radiation oncology at the University of California – San Francisco, and a fellowship in hematology/oncology at Instituto Nacional de Cancer in Rio de Janiero. In addition, she was visiting fellow in the department of hematology/oncology at the University of Tennessee in Memphis. Dr. Rodrigues is Board-certified in radiation oncology.
